In 2024, respiratory system medicine sales in the UK stood at an average of 31.14 US dollars per capita. This figure is forecasted to slightly decrease to 30.82, 30.51, 30.21, and 29.91 over the years up to 2028, reflecting a gradual decline yearly. This trend indicates a subtle negative compound annual growth rate (CAGR) over the next five years.
Future trends to watch for:
- Impact of new respiratory therapies and innovations in medicine.
- Influence of public health initiatives and policy changes on respiratory care.
- Increasing competition and pricing pressures in the pharmaceutical market.
- Potential disruptions in supply chains affecting medicine availability.
